Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
770.00 | -48.73% | -27.69% | 693,312.15 | 0.67% | 2.63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
903.30 | -1.06% | 19.47% | 4,007,181.69 | 1.03% | 18.5% |
|
ENXTBR:ARGX
argenx
|
339.90 | 0% | 0% | 20,200.62 | 0% | 0% |
|
CPSE:GMAB
Genmab A/S
|
2041.00 | 64.8% | 124.4% | 131,830.48 | 0% | 22.71% |
|
NasdaqGS:PODD
Insulet
|
187.27 | 705.17% | 997.4% | 12,431.09 | 0% | 122.88% |
|
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
51.20 | 18.28% | 30.99% | 10,363.08 | 2.36% | 10.99% |
|
LSE:HIK
Hikma Pharmaceuticals PLC
|
19.78 | 25.31% | 38.17% | 4,424.39 | 2.87% | 10.04% |
|
HLSE:ORNBV
Orion Oyj
|
37.69 | 22.61% | 65.62% | 5,117.58 | 4.3% | -0.43% |
|
CPSE:ALK B
ALK-Abelló A/S
|
152.00 | 48.16% | 94.21% | 33,908.31 | 0% | 171.44% |
|
XTRA:MOR
MorphoSys
|
69.35 | 0% | 0% | 2,523.4 | 0% | 0% |
|
LSE:INDV
Indivior PLC
|
13.37 | -23.61% | -1.68% | 1,952.43 | 0% | -2.7% |
|
BME:ALM
Almirall
|
9.27 | -45.22% | 27.15% | 1,944.22 | 2% | -30.96% |
|
NasdaqGS:AMPH
Amphastar Pharmaceuticals
|
43.48 | 226.92% | 260.8% | 2,085.6 | 0% | 73.69% |
|
XTRA:EVT
Evotec
|
9.76 | -32.05% | 101.29% | 1,726.81 | 0% | 0% |
|
SWX:COPN
Cosmo Pharmaceuticals N.V.
|
72.90 | -8.78% | 50.69% | 1,136.54 | 2.68% | -76.88% |
|
BME:FAE
Faes Farma
|
3.66 | 14.51% | 24.13% | 1,089.37 | 4.31% | 6.96% |
|
BME:PHM
Pharma Mar
|
36.72 | 0% | 0% | 536.95 | 1.79% | -39.63% |
|
SWX:BSLN
Basilea Pharmaceutica
|
43.65 | -24.32% | -26.01% | 529.94 | 0% | -15.69% |
|
NasdaqGS:XERS
Xeris Biopharma Holdings
|
1.98 | 0% | 0% | 260.93 | 0% | 0% |
|
ENXTPA:DBV
DBV Technologies
|
1.27 | 0% | 0% | 115.65 | 0% | 0% |
